In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis

BACKGROUND & AIMS: A simultaneous decline in pro‐ and anticoagulant drivers in patients with liver diseases results in a “rebalanced” haemostatic system, even in acutely ill patients. Nevertheless, both bleeding and thrombotic events are common. Here, we explored efficacy of pro‐ and antihaemost...

Descripción completa

Detalles Bibliográficos
Autores principales: Lisman, Ton, Kleiss, Simone, Patel, Vishal C., Fisher, Caleb, Adelmeijer, Jelle, Bos, Sarah, Singanayagam, Arjuna, Stoy, Sidsel H., Shawcross, Debbie L., Bernal, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cirrhos Is and Liver Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220788/
https://www.ncbi.nlm.nih.gov/pubmed/29768734
http://dx.doi.org/10.1111/liv.13882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220788/
https://www.ncbi.nlm.nih.gov/pubmed/29768734
http://dx.doi.org/10.1111/liv.13882

Ejemplares similares